Susi Roger E.'s Form 4 filing
Iradimed Corp (IRMD) · filed Apr 15, 2026
- Accession no.
- 0001613801-26-000024
- Filed
- Apr 15, 2026
- Trade date
- Apr 13-14, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions. Open-market sales total $697.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Susi Roger E.CIK 0001613801 | Director, Officer (CEO, President, Chairman), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Common Stock | SSaleDisposed | −1,847 | $91.84F2 | −$169,628.48 | 2,215,653 | Indirect | |
| Apr 13, 2026 | Common Stock | SSaleDisposed | −2,564 | $92.79F3 | −$237,913.56 | 2,213,089 | Indirect | |
| Apr 13, 2026 | Common Stock | SSaleDisposed | −589 | $93.45F4 | −$55,042.05 | 2,212,500 | Indirect | |
| Apr 14, 2026 | Common Stock | SSaleDisposed | −2,107 | $93.71F5 | −$197,446.97 | 2,210,393 | Indirect | |
| Apr 14, 2026 | Common Stock | SSaleDisposed | −393 | $94.55F6 | −$37,158.15 | 2,210,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $91.28 to $92.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $92.35 to $93.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $93.29 to $94.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $93.17 to $94.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $94.24 to $94.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.